"10.1371_journal.pone.0105853","plos one","2014-08-25T00:00:00Z","Daniele Armenia; Cathia Soulie; Domenico Di Carlo; Lavinia Fabeni; Caterina Gori; Federica Forbici; Valentina Svicher; Ada Bertoli; Loredana Sarmati; Massimo Giuliani; Alessandra Latini; Evangelo Boumis; Mauro Zaccarelli; Rita Bellagamba; Massimo Andreoni; Anne-Geneviève Marcelin; Vincent Calvez; Andrea Antinori; Francesca Ceccherini-Silberstein; Carlo-Federico Perno; Maria Mercedes Santoro","Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy; Unité Mixte de Recherche en Santé (UMR_S) 1136 Pierre Louis Institute of Epidemiology and Public Health, Université Pierre et Marie Curie (UPMC) University Paris 06, Paris, France; UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France; Laboratoire de Virologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe hospitalier Pitié Salpêtrière, Paris, France; Antiviral Drug Monitoring Unit, Istituto Nazionale delle Malattie Infettive (INMI) Lazzaro Spallanzani, Rome, Italy; Molecular Virology, University Hospital Tor Vergata, Rome, Italy; Infectious Disease Unit, University Hospital Tor Vergata, Rome, Italy; Department of Infectious Dermatology, San Gallicano Hospital, Rome, Italy; Infectious Diseases Division, Istituto Nazionale delle Malattie Infettive (INMI) Lazzaro Spallanzani, Rome, Italy","Conceived and designed the experiments: DA MMS CFP FCS. Performed the experiments: CS LF CG AB FF. Analyzed the data: DA CS LF CG DDC MMS VS FCS. Contributed reagents/materials/analysis tools: DDC LF CG FF AB. Wrote the paper: DA DDC CFP MMS. Provided clinical data: CS LS MG AL EB MZ RB MA AGM VC AA.","CFP and FCS are academic editors of PLOS ONE journal. However, this does not alter adherence to PLOS ONE editorial policies and criteria. The authors have no conflicts of interest related to this manuscript. However, VS has received funds for attending symposia, speaking and organizing educational activities from Abbott, Bristol Myers Squibb, Merck Sharp & Dohme, Roche, ViiV Healthcare and Janssen Cilag. MA has received funds for attending symposia, speaking, organizing educational activities and grant research support from Abbvie, Bristol Myers Squibb, Gilead Sciences, ViiV Healthcare. AA has received funds for attending symposia, speaking, grant research support and consultancy from Abbvie, Bristol Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, Janssen Cilag, ViiV Healthcare. FCS has received funds for attending symposia, speaking and organizing educational activities from Abbott, Merck Sharp & Dohme, Gilead, Janssen Cilag, ViiV Healthcare, Roche, and Virco. CFP has received funds for attending symposia, speaking, organizing educational activities, grant research support, consultancy and advisory board membership, from Abbott, Bristol Myers Squibb, Gilead, Merck Sharp & Dohme, Janssen Cilag, Pfizer, Roche, ViiV Healthcare. MMS has received funds for attending symposia, speaking and organizing educational activities from Abbott, Bristol Myers Squibb, Merck Sharp & Dohme, ViiV and Janssen Cilag. This does not alter adherence to PLOS ONE policies on sharing data and materials. The other authors declare no competing interests.","2014","08","Daniele Armenia","DA",21,FALSE,4,5,8,4,TRUE,TRUE,FALSE,0,NA,FALSE
